May 28, 2024

Withdrawn | Cancer Accelerated Approvals

Truseltiq (infigratinib) Treatment of adult patients with previously treated, unresectable locally advanced or metastatic cholangiocarcinoma with fibroblast growth factor receptor 2 (FGFR2) gene fusions or other […]
May 24, 2024

FDA Roundup: May 24, 2024

For Immediate Release: May 24, 2024 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  On Thursday, […]
google.com, pub-5711488453051849, DIRECT, f08c47fec0942fa0